918
Participants
Start Date
December 10, 2019
Primary Completion Date
March 16, 2025
Study Completion Date
March 31, 2025
Sacubitril/valsartan
50 (24/26) mg, 100 (49/51) mg and 200 (97/103) mg will be available for dose adjustments.
Enalapril
5 mg and 10 mg will be available for dose adjustments.
Novartis Investigative Site, San Martín
Novartis Investigative Site, Temperley
Novartis Investigative Site, Rosario
Novartis Investigative Site, Ciudad de
Novartis Investigative Site, Santa Marta
Novartis Investigative Site, Oaxaca City
Novartis Investigative Site, Xalapa
Novartis Investigative Site, Mérida
Novartis Investigative Site, Bogota DC
Novartis Investigative Site, Bogota
Novartis Investigative Site, Florida Blanca
Novartis Investigative Site, Floridablanca
Novartis Investigative Site, San Gil
Novartis Investigative Site, Salvador
Novartis Investigative Site, Brasila
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, Ramos Mejía
Novartis Investigative Site, Villa María
Novartis Investigative Site, Salta
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, Rosario
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Corrientes
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Formosa
Novartis Investigative Site, Formosa
Novartis Investigative Site, Mendoza
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, Santiago del Estero
Novartis Investigative Site, Fortaleza
Novartis Investigative Site, Salvador
Novartis Investigative Site, Salvador
Novartis Investigative Site, Salvador
Novartis Investigative Site, Brasília
Novartis Investigative Site, Brasília
Novartis Investigative Site, Goiânia
Novartis Investigative Site, Goiânia
Novartis Investigative Site, Goiânia
Novartis Investigative Site, São Luís
Novartis Investigative Site, Belo Horizonte
Novartis Investigative Site, Belo Horizonte
Novartis Investigative Site, Belo Horizonte
Novartis Investigative Site, Montes Claros
Novartis Investigative Site, Passos
Novartis Investigative Site, Uberaba
Novartis Investigative Site, Uberlândia
Novartis Investigative Site, Uberlândia
Novartis Investigative Site, Londrina
Novartis Investigative Site, Belém
Novartis Investigative Site, Recife
Novartis Investigative Site, Teresina
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, Natal
Novartis Investigative Site, Botucatu
Novartis Investigative Site, Bragança Paulista
Novartis Investigative Site, Campinas
Novartis Investigative Site, Campinas
Novartis Investigative Site, Campinas
Novartis Investigative Site, Indaiatuba
Novartis Investigative Site, Marília
Novartis Investigative Site, Ribeirão Preto
Novartis Investigative Site, Ribeirão Preto
Novartis Investigative Site, Santo André
Novartis Investigative Site, São José do Rio Preto
Novartis Investigative Site, São José do Rio Preto
Novartis Investigative Site, São José do Rio Preto
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Tatuí
Novartis Investigative Site, Votuporanga
Novartis Investigative Site, Ijuí
Novartis Investigative Site, São Paulo
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY